HomeHeadlinesUK MHRA approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity onlyJANUARY 16, 2026 AT 09:45 AMUK MHRA approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity onlyByNewsquawk StaffImportanceLevel 1#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#GLOBAL EQUITIESExternal
JANUARY 16, 2026 AT 09:45 AMUK MHRA approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity onlyByNewsquawk StaffImportanceLevel 1#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#GLOBAL EQUITIESExternal
